XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Class A Common Stock
Common stock
Common stock
Class A Common Stock
Common stock
Class A Common Stock
Conversion Of Stock By Selling Stockholder Upon Initial Public Offering
Common stock
Class A Common Stock
Conversion Of Class B To Class A
Common stock
Class B Common Stock
Common stock
Class B Common Stock
Conversion Of Stock By Selling Stockholder Upon Initial Public Offering
Common stock
Class B Common Stock
Conversion Of Class B To Class A
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stockholders' Equity, beginning balance $ (231,222)     $ 0     $ 0     $ 186,892 $ (398,199) $ (19,915) $ 0
Convertible preferred stock, beginning balance (in shares) at Jan. 31, 2021 79,551,000                        
Convertible preferred stock, beginning balance at Jan. 31, 2021 $ 424,904                        
Increase (Decrease) in Temporary Equity [Roll Forward]                          
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares) (79,551,000)                        
Conversion of convertible preferred stock to Class B common stock upon initial public offering $ (424,904)                        
Convertible preferred stock, ending balance (in shares) at Jan. 31, 2022 0                        
Convertible preferred stock, ending balance at Jan. 31, 2022 $ 0                        
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2021       1,151,000     52,468,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of stock (in shares)         2,500,000 14,550,000 79,551,000 (2,500,000) (14,550,000)        
Conversion of stock 424,904                 424,904      
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs (in shares)       8,940,000                  
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs 649,845                 649,845      
Issuance of common stock in connection with business combination, net (in shares)             26,000            
Issuance of common stock in connection with business combination, net 959                 959      
Contingent stock consideration in connection with business combination 1,754                 1,754      
Repurchase of common stock (in shares)             (13,000)            
Repurchase of common stock $ (590)                 (590)      
Issuance of common stock related to vested exercised stock options (in shares) 4,789,000           4,118,000            
Issuance of common stock related to vested exercised stock options $ 19,408                 19,408      
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)             574,000            
Vesting of early exercised stock options 7,212                 7,212      
Warrant exercised (in shares)             73,000            
Warrant exercised 86                 86      
Stock-based compensation expense 30,009                 30,009      
Change in noncontrolling interest ownership 26,450                       26,450
Foreign currency translation adjustments 28,014                     27,639 375
Net loss (157,560)                   (155,138)   (2,422)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2022       27,141,000     119,747,000            
Stockholders' Equity, ending balance at Jan. 31, 2022 799,269     $ 0     $ 0     1,320,479 (553,337) 7,724 24,403
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stockholders' Equity, beginning balance $ 799,269     $ 0     $ 0     1,320,479 (553,337) 7,724 24,403
Convertible preferred stock, ending balance (in shares) at Jan. 31, 2023 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of stock (in shares)       66,162,000     (66,162,000)            
Repurchase of common stock (in shares)             (36,000)            
Issuance of common stock related to vested exercised stock options (in shares) 2,964,000           2,940,000            
Issuance of common stock related to vested exercised stock options $ 24,846                 24,846      
Issuance of common stock under employee stock purchase plan (in shares)       437,000                  
Issuance of common stock under employee stock purchase plan 14,378                 14,378      
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)       915,000                  
Vesting of early exercised stock options 4,706                 4,706      
Stock-based compensation expense 122,567                 114,811     7,756
Change in noncontrolling interest ownership 61,726                 18,153     43,573
Deconsolidation of Arch, formerly Meltano (11,342)                       (11,342)
Other comprehensive income (loss) (10,729)                     (8,429) (2,300)
Net loss (180,696)                   (172,311)   (8,385)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2023       94,655,000     56,489,000            
Stockholders' Equity, ending balance at Jan. 31, 2023 824,725 [1]     $ 0     $ 0     1,497,373 (725,648) (705) 53,705
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stockholders' Equity, beginning balance $ 824,725 [1]     $ 0     $ 0     1,497,373 (725,648) (705) 53,705
Convertible preferred stock, ending balance (in shares) at Jan. 31, 2024 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of stock (in shares)       16,995,000     (16,995,000)            
Repurchase of common stock (in shares)             (13,000)            
Issuance of common stock related to vested exercised stock options (in shares) 3,406,000           3,406,000            
Issuance of common stock related to vested exercised stock options $ 32,448                 32,448      
Issuance of common stock under employee stock purchase plan (in shares)       417,000                  
Issuance of common stock under employee stock purchase plan 12,933                 12,933      
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)       2,372,000                  
Charitable donation of common stock (in shares)   231,408 231,000                    
Charitable donation of common stock 10,700 $ 10,700               10,700      
Vesting of early exercised stock options 1,234                 1,234      
Stock-based compensation expense 163,049                 164,515     (1,466)
Change in noncontrolling interest ownership                   (542)     542
Other comprehensive income (loss) 878                     3,040 (2,162)
Net loss (428,033)                   (424,174)   (3,859)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2024       114,670,000     42,887,000            
Stockholders' Equity, ending balance at Jan. 31, 2024 617,934 [1]     $ 0     $ 0     1,718,661 (1,149,822) 2,335 46,760
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stockholders' Equity, beginning balance $ 617,934 [1]     $ 0     $ 0     $ 1,718,661 $ (1,149,822) $ 2,335 $ 46,760
[1]
(1) As of January 31, 2024 and January 31, 2023, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $47.6 million and $62.8 million, respectively, and liabilities of $6.1 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.